Nasdaq: RXRX
Recursion Pharmaceuticals insiders
The officers, directors and 10% owners of Recursion Pharmaceuticals, Inc. who hold the most stock, valued at the live RXRX price.
$2.74
RXRX today −$90K (−3.19%)
Live prices, last trade 3:35 PM ET
- Ranked insiders
- 6
- Their RXRX stock
- $52.6M
- Market value
- $1.81B
- Held by ranked insiders
- 2.90%
Insiders by value of RXRX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Christopher Gibson | Director | 6,071,069 | $16.6M | 0.92% | 5898th |
| 2 | Blake Borgeson | Director | 6,068,287 | $16.6M | 0.91% | 5964th |
| 3 | Dean Y. Li | Director | 3,456,736 | $9.5M | 0.52% | 4835th |
| 4 | Najat Khan | CEO and President | 1,987,075 | $5.4M | 0.30% | 13677th |
| 5 | Michael Secora | Chief Financial Officer | 1,487,694 | $4.1M | 0.22% | 10316th |
| 6 | Fred Hassan | Director | 156,658 | $428K | <0.1% | 9310th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Recursion Pharmaceuticals; see each profile for the filing.